vs
MIMEDX GROUP, INC.（MDXG）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是MIMEDX GROUP, INC.的1.9倍（$225.0M vs $118.1M），MIMEDX GROUP, INC.同比增速更快（27.1% vs 24.9%），过去两年MIMEDX GROUP, INC.的营收复合增速更高（18.1% vs -12.3%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
MDXG vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.9倍
$118.1M
营收增速更快
MDXG
高出2.2%
24.9%
两年增速更快
MDXG
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $225.0M |
| 净利润 | $15.2M | — |
| 毛利率 | 83.9% | 25.3% |
| 营业利润率 | 17.8% | 7.9% |
| 净利率 | 12.9% | — |
| 营收同比 | 27.1% | 24.9% |
| 净利润同比 | 104.2% | — |
| 每股收益（稀释后） | $0.10 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGROCK
| Q4 25 | $118.1M | $225.0M | ||
| Q3 25 | $113.7M | $310.9M | ||
| Q2 25 | $98.6M | $309.5M | ||
| Q1 25 | $88.2M | $290.0M | ||
| Q4 24 | $92.9M | $180.1M | ||
| Q3 24 | $84.1M | $277.1M | ||
| Q2 24 | $87.2M | $273.6M | ||
| Q1 24 | $84.7M | $292.5M |
净利润MDXGROCK
| Q4 25 | $15.2M | — | ||
| Q3 25 | $16.7M | $-89.1M | ||
| Q2 25 | $9.6M | $26.0M | ||
| Q1 25 | $7.0M | $21.1M | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $8.1M | $34.0M | ||
| Q2 24 | $17.6M | $32.2M | ||
| Q1 24 | $9.3M | $24.9M |
毛利率MDXGROCK
| Q4 25 | 83.9% | 25.3% | ||
| Q3 25 | 83.5% | 26.6% | ||
| Q2 25 | 81.1% | 28.4% | ||
| Q1 25 | 81.2% | 26.8% | ||
| Q4 24 | 81.8% | 29.0% | ||
| Q3 24 | 81.8% | 29.4% | ||
| Q2 24 | 83.0% | 30.5% | ||
| Q1 24 | 84.7% | 28.9% |
营业利润率MDXGROCK
| Q4 25 | 17.8% | 7.9% | ||
| Q3 25 | 19.5% | 12.8% | ||
| Q2 25 | 12.5% | 12.8% | ||
| Q1 25 | 9.4% | 8.8% | ||
| Q4 24 | 11.9% | 13.3% | ||
| Q3 24 | 13.3% | 15.6% | ||
| Q2 24 | 26.9% | 14.9% | ||
| Q1 24 | 15.6% | 10.8% |
净利率MDXGROCK
| Q4 25 | 12.9% | — | ||
| Q3 25 | 14.7% | -28.6% | ||
| Q2 25 | 9.8% | 8.4% | ||
| Q1 25 | 8.0% | 7.3% | ||
| Q4 24 | 8.0% | — | ||
| Q3 24 | 9.6% | 12.3% | ||
| Q2 24 | 20.2% | 11.8% | ||
| Q1 24 | 10.9% | 8.5% |
每股收益（稀释后）MDXGROCK
| Q4 25 | $0.10 | — | ||
| Q3 25 | $0.11 | $-2.98 | ||
| Q2 25 | $0.06 | $0.87 | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.05 | $1.11 | ||
| Q2 24 | $0.12 | $1.05 | ||
| Q1 24 | $0.06 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $115.7M |
| 总债务越低越好 | $18.0M | $0 |
| 股东权益账面价值 | $256.5M | $950.4M |
| 总资产 | $342.7M | $1.4B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资MDXGROCK
| Q4 25 | $166.1M | $115.7M | ||
| Q3 25 | $142.1M | $89.4M | ||
| Q2 25 | $118.9M | $43.3M | ||
| Q1 25 | $106.4M | $25.1M | ||
| Q4 24 | $104.4M | $269.5M | ||
| Q3 24 | $88.8M | $228.9M | ||
| Q2 24 | $69.0M | $179.1M | ||
| Q1 24 | $48.5M | $146.7M |
总债务MDXGROCK
| Q4 25 | $18.0M | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | $19.0M | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益MDXGROCK
| Q4 25 | $256.5M | $950.4M | ||
| Q3 25 | $238.9M | $951.8M | ||
| Q2 25 | $216.6M | $1.0B | ||
| Q1 25 | $202.8M | $1.0B | ||
| Q4 24 | $193.1M | $1.0B | ||
| Q3 24 | $181.0M | $1.0B | ||
| Q2 24 | $168.0M | $975.7M | ||
| Q1 24 | $155.7M | $940.2M |
总资产MDXGROCK
| Q4 25 | $342.7M | $1.4B | ||
| Q3 25 | $319.0M | $1.4B | ||
| Q2 25 | $291.1M | $1.5B | ||
| Q1 25 | $270.4M | $1.4B | ||
| Q4 24 | $263.9M | $1.4B | ||
| Q3 24 | $243.9M | $1.4B | ||
| Q2 24 | $230.2M | $1.4B | ||
| Q1 24 | $221.7M | $1.3B |
负债/权益比MDXGROCK
| Q4 25 | 0.07× | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.10× | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | — | $26.2M |
| 自由现金流率自由现金流/营收 | — | 11.7% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | $120.6M |
8季度趋势，按日历期对齐
经营现金流MDXGROCK
| Q4 25 | $25.0M | $35.5M | ||
| Q3 25 | $29.3M | $73.0M | ||
| Q2 25 | $14.4M | $44.9M | ||
| Q1 25 | $5.3M | $13.7M | ||
| Q4 24 | $18.8M | $19.9M | ||
| Q3 24 | $19.6M | $64.7M | ||
| Q2 24 | $21.8M | $36.5M | ||
| Q1 24 | $6.0M | $53.2M |
自由现金流MDXGROCK
| Q4 25 | — | $26.2M | ||
| Q3 25 | — | $64.8M | ||
| Q2 25 | — | $27.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | — | $60.5M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $48.8M |
自由现金流率MDXGROCK
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 20.8% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | 12.2% | ||
| Q1 24 | — | 16.7% |
资本支出强度MDXGROCK
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.5% |
现金转化率MDXGROCK
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.50× | 1.73× | ||
| Q1 25 | 0.75× | 0.65× | ||
| Q4 24 | 2.53× | — | ||
| Q3 24 | 2.42× | 1.90× | ||
| Q2 24 | 1.24× | 1.13× | ||
| Q1 24 | 0.65× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
